View All Key Stats
DRRX Key Stats
| Income Statement | |
| Revenue (TTM) | 16.15M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.25 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -35.68M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 78.61% |
| Profit Margin (Quarterly) | -229.8% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 239.61M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 14.18 |
| PE Ratio (TTM) | -- |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -10.82 |
| Free Cash Flow (Quarterly) | 12.48M |
| Return on Equity (TTM) | -426.3% |
View All DRRX News
DRRX News
-
WireHeadlineTime (ET)
-
PR Newswire09/11 16:05
-
PR Newswire09/05 16:15
-
SA Breaking News08/25 08:13
-
Yahoo08/14 08:59
-
SA Breaking News08/11 03:43
-
Yahoo08/10 14:00
-
Yahoo08/08 23:56
-
MT Newswires08/08 17:03
-
PR Newswire08/08 16:05
-
SA Breaking News08/08 09:21
View All Events
DRRX Events
| Date | Type | Description |
|---|---|---|
| 08/08/2017 16:30 EDT | Misc | Durect Corp Second Quarter Earnings Conference Call in 2017 |
| 08/08/2017 | Earnings | Durect Corp Second Quarter Earnings in 2017 Release |
| 06/19/2017 | Misc | Durect Corp Annual General Meeting in 2016 |
| 05/10/2017 16:30 EDT | Misc | Durect Corp First Quarter Earnings Conference Call in 2017 |
| 05/10/2017 | Earnings | Durect Corp First Quarter Earnings in 2017 Release |
| 03/14/2017 16:30 EDT | Misc | Durect Corp Fourth Quarter Earnings Conference Call in 2016 |
| 03/14/2017 | Earnings | Durect Corp Fourth Quarter Earnings in 2016 Release |
| 10/31/2016 16:30 EDT | Misc | Durect Corp Third Quarter Earnings Conference Call in 2016 |
| 10/31/2016 | Earnings | Durect Corp Third Quarter Earnings in 2016 Release |
DRRX Fundamentals
Income Statement View Statement
DRRX Ratings
Advertisement
DRRX One Page Reports
- One Page Report Download
DRRX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 1.63 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.durect.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-IRHome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 08, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Durect Corp is a biopharmaceutical company. It develops pharmaceutical products based on two categories which include new chemical entities and Drug Delivery Programs.
DRRX Comparables
EditDRRX Excel Add-In Codes
- Name: =YCI("DRRX","name")
- Description: =YCI("DRRX","description")
- Sector: =YCI("DRRX","sector")
- Industry: =YCI("DRRX","industry")
- Est. Current Fiscal Year End: =YCI("DRRX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other DRRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- DRRX Tweets Stocktwits
Advertisement
